Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

This study is currently recruiting participants.

Study NCT00910000 Information provided by Dana-Farber Cancer Institute

First Received: May 26, 2009 Last Updated: December 29, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	March 2011 (Final data collection date for primary outcome measure)